Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Myocardial delivery of labeled fibroblast growth factor-2 protein by high pressure, retrograde coronary venous injection is more efficient than intracoronary administration American-Heart-Association Abstracts From Scientific Sessions Fearon, W. F., Ikeno, F., Price, E., Bailey, L. R., Herity, N. A., Fitzgerald, P. J., Rezaee, M., Yeung, A. C., Yock, P. G. LIPPINCOTT WILLIAMS & WILKINS. 2002: 656–56
View details for Web of Science ID 000179142703274